Stock Price & Analysis

The S1 support level for HUMA Stock is $3.14 ,The R1 resistant level for HUMA Stock is $4.03.

As of the end of day on 2025-02-27, the price of HUMA Stock was $3.87.

The target price for HUMA Stock according to analyst rating is 13.00, with the highest price target at 17.00 and the lowest at 10.00. Analysts have a Strong Buy rating on HUMA Stock overall.

The market cap of HUMA is $420.7M.

Humacyte, Inc. is engaged in the development and manufacturing of off-the-shelf, universally implantable, bioengineered human tissues. It is engaged in developing a portfolio of human acellular vessels (HAVs) with varying diameters and lengths. The HAV cabinet would initially target the vascular repair, reconstruction and replacement market, including vascular trauma; atrioventricular (AV) access for hemodialysis; peripheral arterial disease (PAD); and coronary artery bypass grafting (CABG). The Company has developed a novel paradigm for manufacturing human tissues that are intended to mimic key aspects of human physiology. It is also engaged in developing its HAVs for pediatric heart surgery and the delivery of cellular therapies, including pancreatic islet cell transplantation to treat Type 1 diabetes. Its scientific technology platform uses primary human aortic vascular cells from a working cell stock, isolated from donor tissues and cryopreserved.

HUMA has a total of 183 employees.